Quoting from the Feb 11 article by Greg Avery:
"The CBSA has joined Washington, D.C.-based trade groups such as MDMA and AdvaMed in urging the state’s and other congressional delegations to repeal the tax, and to make other adjustments to the Affordable Care Act (ACA), though the industry supports many of its features.
Drug makers have particular concerns about one part of the ACA. The law creates a panel of presidential appointees with the power to alter reimbursement levels for drugs sold through Medicare and Medicaid, and the ability to appeal the panel’s decision isn’t defined, said Holli Baumunk, president and CEO of the CBSA.
Because of legislation in Congress to repeal or alter parts of the act, and a federal court fight over whether the government can require people to buy health insurance, there’s a lot of uncertainty clouding U.S. bioscience — and that undermines the country’s lead in the field, she said.
'People are trying to get a read on what will happen, and there’s just too many unknowns,' Baumunk said. 'Nationally, we see companies looking at developing [new products] in Europe and Asia first because they don’t know what’ll happen here.'"
Link to the Denver Business Journal article online
CEO Panel presenters at the Feb 17 BioPharma Symposium are featured in the current Denver Business Journal in an article by Technology Report Greg Avery. CEOs included: Steve Orndorff, Ariel Pharmaceuticals; Tim Rodell, GlobeImmune; and Robert Conway, Array BioPharma. This was the launch of the 2011 CBSA Symposium series, to be held quarterly.
The CBSA's current newsletter spotlights Medtronic Navigation's New Education Center in Louisville, CO. - plus more....
CBSA President & CEO Holli Baumunk interviewed on 9News this morning with Gary Shapiro about job opportunities in Colorado's Bioscience Industry and shared details about today's Biotech & Pharma Symposium, 1-7 at the Denver Grand Hyatt.
CBSA President & CEO Holli Baumunk interviewed on the Radio Colorado Network's Business for Breakfast broadcast this morning, about the association's upcoming launch of its 2011 Symposium Series. She interviewed with Business For Breakfast Co-Host Woody Vincent.
Quoting from the Feb 11 article by Ed Sealover:
Quoting from the Feb 11 article by Greg Avery:
Quoting from the Denver Post website:
The Colorado BioScience Association (CBSA) and The Colorado Office of Economic Development and International Trade (OEDIT) have jointly released results of the Bioscience Discovery Evaluation Grant Program (BDEGP) at the CBSA's Third Annual "Bioscience Day at the Capitol" event. The announcement is made by Holli Baumunk, CBSA President & CEO, who says the BDEGP has more than met expectations since its inception in 2006, providing the state a significant return on investment.
